ArticleJournal of controlled release : official journal of the Controlled Release Society2018

Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.

Jahidur Rashid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.